This inventor holds 9 USPTO granted patents and 12 published patent applications and 4 EPO patents. Top assignees: Jiangsu Jiuhui Technology Co., Ltd., Qyuns Therapeutics Co., Ltd., Qyuns Therapeutics Co., Ltd.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taizhou, CN (2023)
- Jiangsu, CN (2018 - 2024)
Company Filing History:

Years Active: 2018-2026
Title: Innovations and Contributions of Inventor Tao Chen
Introduction
Tao Chen is a prominent inventor based in Jiangsu, China, known for his significant contributions to the field of biotechnology. With a total of seven patents to his name, he has made remarkable advancements in the development of monoclonal antibodies for therapeutic applications.
Latest Patents
Among his latest patents is the invention of an anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody. This antibody exhibits high affinity for human TSLP and possesses neutralizing activity, making it a potential treatment for TSLP-mediated diseases. Another notable patent is the anti-human interleukin-33 monoclonal antibody, which also demonstrates high affinity and neutralizing activity, aimed at preventing or treating diseases mediated by human interleukin-33.
Career Highlights
Tao Chen has worked with several companies, including Qyuns Therapeutics Co., Ltd. and Jiangsu Jiuhui Technology Co., Ltd. His work in these organizations has been instrumental in advancing research and development in the field of monoclonal antibodies.
Collaborations
Tao Chen has collaborated with notable colleagues such as Jiwan Qiu and Wei Chen, contributing to various projects that enhance the understanding and application of monoclonal antibodies in medicine.
Conclusion
Tao Chen's innovative work in the field of biotechnology, particularly in monoclonal antibodies, showcases his dedication to advancing medical treatments. His contributions are paving the way for new therapeutic options in the fight against various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile